Entrada Therapeutics, Inc. (NASDAQ: TRDA) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT ENTRADA THERAPEUTICS, INC.

Entrada Therapeutics, Inc. (NASDAQ: TRDA)
Listen to this Section

$7.28
+0.1260 ( +1.76% ) 91.4K

Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.

Market Data
Open $7.28
Previous Close $7.15
Volume 91.4K
Market Cap $292.71M
Day Range $7.12 - $7.63
52 Week Range $4.93 - $16.45
Shares Outstanding 38.82M
Change % +1.76%
Net Change ▲ 0.1260
Insider Ownership -0.01%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2021
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: 284,338.00

Date Type Amount Purchased Purchaser
2025-11-12 Buy 2296.00 BAKER BROS. ADVISORS LP
2024-07-16 Sale -300.00 Doshi Dipal
2024-07-16 Sale -600.00 Sethuraman Natarajan
2024-07-10 Sale -1758.00 WENTWORTH KORY JAMES
2024-06-26 Buy 285700.00 BAKER BROS. ADVISORS LP
2023-08-16 Sale -1000.00 Doshi Dipal

SEC Filings

Form Type Description Pages Date
4 Insider transactions 1 Jun 03, 2025
3 Insider transactions 4 Jun 03, 2025
8-k 8K-related 15 Jun 03, 2025

Latest News

About US

Services

Stay Connected